Help us improve our website

Search

Type

Audience

Category

Issue

Last updated

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 15 of 15 items.

" " GILENYA (fingolimod) - Risk of Congenital Malformations
GILENYA (fingolimod) - Risk of Congenital Malformations Starting date: December 19, 2019 Posting date: December 19, 2019 Type of communication: Dear Healthcare Professional…
AlertHealth professional risk communication | 2019-12-19
" " XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis Starting date: December 2, 2019 Posting date: December 2, 2019 Type of communication: Dear Healthcare Professional…
AlertHealth professional risk communication | 2019-12-02
" " ULORIC ® (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes
ULORIC ® (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes Starting date: November 4, 2019 Posting date: November 4, 2019 Type of communication: Dear Healthcare…
AlertHealth professional risk communication | 2019-11-04
" " LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions Starting date: October 15, 2019…
AlertHealth professional risk communication | 2019-10-15
" " Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring Starting date: October 9, 2019 Posting date: October 9, 2019 Type of communication:…
AlertHealth professional risk communication | 2019-10-09
" " Tacrolimus and the Risk of Graft Rejection due to Medication Errors: Inadvertent Switching between Different Oral Formulations
Tacrolimus and the Risk of Graft Rejection due to Medication Errors: Inadvertent Switching between Different Oral Formulations…
AlertHealth professional risk communication | 2019-07-22
" " ALERTEC (modafinil) and the Risk of Congenital Anomalies
ALERTEC (modafinil) and the Risk of Congenital Anomalies Starting date: June 20, 2019 Posting date: June 20, 2019 Type of communication: Dear Healthcare Professional Letter…
AlertHealth professional risk communication | 2019-06-20
" " Important Safety Information on Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion
Important Safety Information on Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion Starting date: April 28, 2019 Posting date: May 30, 2019 Type of…
AlertHealth professional risk communication | 2019-05-30
" " Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity Starting date: May 21, 2019 Posting date: May 21, 2019 Type of communication: Dear Healthcare…
AlertHealth professional risk communication | 2019-05-21
" " Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality
Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality…
AlertHealth professional risk communication | 2019-05-06
" " Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation Starting date: April 17, 2019 Posting date: April 17, 2019 Type…
AlertHealth professional risk communication | 2019-04-17
" " PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury Starting date: April 4, 2019 Posting date: April 4, 2019 Type of…
AlertHealth professional risk communication | 2019-04-04
" " DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation Starting date: March 25, 2019 Posting date: March 25, 2019 Type of communication: Dear Healthcare Professional Letter…
AlertHealth professional risk communication | 2019-03-25
" " TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis Starting date: March 13, 2019 Posting date: March 13, 2019 Type of communication: Dear Healthcare Professional…
AlertHealth professional risk communication | 2019-03-13
" " LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions Starting date: January 30, 2019 Posting date: January 30, 2019 Type of communication…
AlertHealth professional risk communication | 2019-01-30
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.